Announcements
Crimson Tide PLC : Significant long term contract win
RNS Number : 4017M
Crimson Tide PLC
13 October 2016
Crimson Tide PLC
("Crimson Tide" or the 'Company')
Significant long term contract win with large UK retailer
Crimson Tide ﴾TIDE﴿, the AIM‐quoted provider of mpro5 ‐ Smart Mobility as a Service, has signed its most significant long term contract with a large UK retailer. Its mpro5 service will be used to ensure store safety, cleanli
Boston International : Admission to Trading and First Day of Dealings
RNS Number : 2669M
Boston International Holdings PLC
12 October 2016
12 October 2016
Boston International Holdings plc
("BIH" or the "Company")
Admission to Trading and First Day of Dealings
Boston International Holdings plc, a special purpose acquisition company (SPAC) formed to undertake one or more acquisitions of target companies or businesses i
Crimson Tide PLC : Long Term Contract with NCHCD
RNS Number : 2818M
Crimson Tide PLC
12 October 2016
Crimson Tide PLC
("Crimson Tide" or the 'Company')
Crimson Tide signs long term contract with National Centre for Hereditary Coagulation Disorders (NCHCD)
Crimson Tide ﴾TIDE﴿, the AIM‐quoted provider of mpro5 ‐ Smart Mobility as a Service, has entered into a contract with the NCHCD in Ireland, whereby mpro5 will deliver its healthc
Neville Registrars welcomes Boston International Holdings Plc
Neville Registrars is delighted to welcome Boston International Holdings Plc as the newest addtion to its list of client companies.
Boston International Holdings is a special purpose acquisition company listed on the standard segment of the official list, with shares traded on the main market of the London Stock Exchange, which is seeking to acquire a business operating in the foreign exchange sector.
Further information can be found on the Company'
WANdisco Plc : WANdisco secures two new record contracts
RNS Number : 0768M
WANdisco Plc
10 October 2016
10 October 2016
WANdisco plc
("WANdisco" or the "Company")
WANdisco secures two new record contracts
Big Data contract
WANdisco (LSE: WAND) a leading provider of enterprise-ready, non-stop software solutions, is pleased to announc
Mission Marketing : Launch of new Sales Promotion business
RNS Number : 0439M
The Mission Marketing Group PLC
10 October 2016
Launch of new Sales Promotion business
The Mission Marketing Group plc ('the missiontm', "the Company", AIM: TMMG), the marketing communications and advertising group, has today announced the launch of Mongoose Promotions, a specialist sales promotion business. Sales promotion is a technique to help Clients better understand the behaviour of their customers and to creat
Powerhouse Enrgy Grp : New video showcasing G3-UHt unit in operation
RNS Number : 5679L
Powerhouse Energy Group PLC
04 October 2016
4 October 2016
PowerHouse Energy Group plc
("PowerHouse" or the "Company")
PowerHouse Energy publishes new video showcasing G3-UHt unit in operation
PowerHouse (AIM: PHE), the company focused on ultra high gasif
BMR Group PLC : ISF Slag Laboratory Tests Completed
RNS Number : 4491L
BMR Group PLC
03 October 2016
3 October 2016
BMR Group PLC ("BMR" or the "Company")
ISF Slag Laboratory Tests Completed
On 1 June 2016, the Company announced that, in co-operation with Kupfermelt Metal Processing CC, its metallurgical partner, a recovery of 77.2% Zn had been achieved from the ISF Slag (ISFS), albeit at a cost of high sulphuric acid consumption.
Neville Registrars welcomes PBF Holdings Limited
Neville Registrars is delighted to welcome PBF Holdings Limited as the newest addtion to its list of client companies.
PBF Solutions delivers performance marketing, customer acquisition technology and consultancy solutions to retail banks, peer-to-peer product providers and other financial institutions
Further information can be found on the Company's website: http://pbfsolutions.co.uk/
Midatech Pharma PLC : First in Human Immunotherapy Study Start
RNS Number : 2621L
Midatech Pharma PLC
30 September 2016
30 September 2016
Midatech Pharma PLC
("Midatech" or the "Company")
Commencement of First in Human Immunotherapy Study Using Gold Nanoparticle Technology
Midatech (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialisin
